These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28691930)

  • 1. Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.
    Jung K; Heishi T; Khan OF; Kowalski PS; Incio J; Rahbari NN; Chung E; Clark JW; Willett CG; Luster AD; Yun SH; Langer R; Anderson DG; Padera TP; Jain RK; Fukumura D
    J Clin Invest; 2017 Aug; 127(8):3039-3051. PubMed ID: 28691930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CXCR4-dependent immunosuppressive Ly6C
    Jung K; Heishi T; Incio J; Huang Y; Beech EY; Pinter M; Ho WW; Kawaguchi K; Rahbari NN; Chung E; Kim JK; Clark JW; Willett CG; Yun SH; Luster AD; Padera TP; Jain RK; Fukumura D
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10455-10460. PubMed ID: 28900008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
    White GE; McNeill E; Channon KM; Greaves DR
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2554-62. PubMed ID: 25359863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice.
    Jacquelin S; Licata F; Dorgham K; Hermand P; Poupel L; Guyon E; Deterre P; Hume DA; Combadière C; Boissonnas A
    Blood; 2013 Aug; 122(5):674-83. PubMed ID: 23775714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
    Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
    Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade.
    Rigamonti N; Kadioglu E; Keklikoglou I; Wyser Rmili C; Leow CC; De Palma M
    Cell Rep; 2014 Aug; 8(3):696-706. PubMed ID: 25088418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the fractalkine-CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes.
    Kuboi Y; Nishimura M; Ikeda W; Nakatani T; Seki Y; Yamaura Y; Ogawa K; Hamaguchi A; Muramoto K; Mizuno K; Ogasawara H; Yamauchi T; Yasuda N; Onodera H; Imai T
    Int Immunol; 2019 Apr; 31(5):287-302. PubMed ID: 30668715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages.
    Donnelly DJ; Longbrake EE; Shawler TM; Kigerl KA; Lai W; Tovar CA; Ransohoff RM; Popovich PG
    J Neurosci; 2011 Jul; 31(27):9910-22. PubMed ID: 21734283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes.
    Liu C; Luo D; Streit WJ; Harrison JK
    J Neuroimmunol; 2008 Jul; 198(1-2):98-105. PubMed ID: 18508133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ly6Chigh Monocytes Protect against Kidney Damage during Sepsis via a CX3CR1-Dependent Adhesion Mechanism.
    Chousterman BG; Boissonnas A; Poupel L; Baudesson de Chanville C; Adam J; Tabibzadeh N; Licata F; Lukaszewicz AC; Lombès A; Deterre P; Payen D; Combadière C
    J Am Soc Nephrol; 2016 Mar; 27(3):792-803. PubMed ID: 26160897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
    Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
    Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular expression of the chemokine CX3CL1 promotes osteoclast recruitment and exacerbates bone resorption in an irradiated murine model.
    Han KH; Ryu JW; Lim KE; Lee SH; Kim Y; Hwang CS; Choi JY; Han KO
    Bone; 2014 Apr; 61():91-101. PubMed ID: 24401612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.
    Morimura S; Sugaya M; Sato S
    Am J Pathol; 2013 May; 182(5):1640-7. PubMed ID: 23470165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
    Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
    PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.
    Peng X; Zhang J; Xiao Z; Dong Y; Du J
    J Immunol; 2015 Sep; 195(6):2797-805. PubMed ID: 26254342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.
    Yamamoto S; Kato A; Sakurai Y; Hada T; Harashima H
    J Control Release; 2017 Apr; 251():1-10. PubMed ID: 28192155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "γδT Cell-IL17A-Neutrophil" Axis Drives Immunosuppression and Confers Breast Cancer Resistance to High-Dose Anti-VEGFR2 Therapy.
    Zhang Z; Yang C; Li L; Zhu Y; Su K; Zhai L; Wang Z; Huang J
    Front Immunol; 2021; 12():699478. PubMed ID: 34721375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
    Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
    Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of CX
    Becker F; Holthoff C; Anthoni C; Rijcken E; Alexander JS; Gavins FN; Spiegel HU; Senninger N; Vowinkel T
    Int J Colorectal Dis; 2017 Mar; 32(3):315-324. PubMed ID: 27942903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.
    Cochain C; Rodero MP; Vilar J; Récalde A; Richart AL; Loinard C; Zouggari Y; Guérin C; Duriez M; Combadière B; Poupel L; Lévy BI; Mallat Z; Combadière C; Silvestre JS
    Cardiovasc Res; 2010 Oct; 88(1):186-95. PubMed ID: 20501509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.